Testing effectiveness (Phase 2)Active Not RecruitingNCT06655896
What this trial is testing
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis
Who this might be right for
Scleroderma, Diffuse
Novartis Pharmaceuticals 96